A new Nielsen survey tells us that sales of hemp-derived CBD beauty and cosmetic products – including face lotions, serums, and skin nourishment/replenishment products – could almost double in 2021 to $600 million and may top $2 billion by 2025. (CBD’s ability to improve the skin is based on its anti-inflammatory properties.)
This demand, the survey says, will be driven primarily by women, especially those under the age of 35.
Importantly, though, this burgeoning category does not include cannabis-derived CBD used for medical purposes such as chronic pain & inflammation, or anxiety, sleep & depression – the leading reasons that men & women in the 35 – 75 age group use CBD.
All these conditions may be just the beginning. As the legal barriers fall and medical cannabis research picks up, it seems we’re on the verge of a whole new way of treating age-old conditions. As Harvard’s Peter Grinspoon, MD, put it the other day in a piece about the evolving role of the endocannabinoid system (ECS) in medical treatment:
We are truly at the dawn of an age of discovery of the ECS and the development of new medicines that may help alleviate some of the cruelest diseases that people (and animals) suffer from. I am incredibly excited to see what discoveries await us as we continue to untangle the mysteries of the ECS.